Using GeriKit to assess older adults with heart disease
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
This study is testing a mobile app called GeriKit to see if it can help doctors better understand and assess older adults with heart disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 75 Years to 100 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05788666 on ClinicalTrials.gov |
What this trial studies
This study aims to utilize the NYU GeriKit mobile application to better phenotype older patients with ischemic heart disease. It is a single-center proof of concept study conducted at NYU Langone Medical Center, focusing on geriatric impairments and feasibility metrics. The GeriKit app is designed to make geriatric assessment tools accessible to clinicians without specialized geriatrics training, and while it has been used clinically, this study will explore its application in a research context.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 75 and above who are currently hospitalized for acute myocardial infarction, percutaneous coronary intervention, or coronary artery bypass grafting.
Not a fit: Patients who are non-ambulatory or have moderate to severe cognitive impairment may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve the assessment and management of older adults with ischemic heart disease, leading to better patient outcomes.
How similar studies have performed: While the GeriKit app has been used in clinical settings, this specific application in a research context is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 75 2. Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks 3. Capable of self-consent 4. Understand and are able to perform study procedures in English Exclusion Criteria: 1. Non-ambulatory 2. Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia) 3. Unable or unwilling to consent 4. Incarcerated 5. Unable to use complete assessments in English 6. Unable to complete geriatric assessment for other reasons
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: John A. Dodson, MD, MPH, FACC — NYU Langone Health
- Study coordinator: John A. Dodson, MD, MPH, FACC
- Email: Cdhlab@nyulangone.org
- Phone: (646) 501-2714
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.